Chugai Pharmaceutical Co., Ltd.

General ticker "CHGCF" information:

Chugai Pharmaceutical Co., Ltd. does not follow the US Stock Market performance with the rate: -11.2%.

Estimated limits based on current volatility of 2.4%: low 42.85$, high 44.99$

Factors to consider:

Company pays dividends (annually): last record date 2026-06-30, amount 0.41$ (Y0.95%)
Price in estimated range
Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

YTD	2023-12-31	2024-12-31	2025-12-31
Operating Revenue	¥1,111,367.00MM	¥1,170,611.00MM	¥1,259,038.69MM
Operating Expenses	¥672,193.00MM	¥628,609.00MM	¥668,331.69MM
Operating Income	¥439,174.00MM	¥542,002.00MM	¥590,707.01MM
Non-Operating Income	¥4,647.00MM	¥1,032.00MM	¥7,621.65MM
Interest Expense	¥0.00MM	¥0.00MM	¥1,026.89MM
R&D Expense	¥174,868.00MM	¥181,440.00MM	¥187,761.70MM
Income(Loss)	¥443,821.00MM	¥543,034.00MM	¥598,328.65MM
Taxes	¥118,349.00MM	¥155,717.00MM	¥163,936.93MM
Net Income(Loss)*	¥325,472.00MM	¥185,088.00MM	¥434,390.72MM
Stockholders Equity	¥1,625,580.00MM	¥1,901,499.00MM	¥2,027,499.68MM
Inventory	¥273,480.00MM	¥240,067.00MM	¥277,089.58MM
Assets	¥1,932,547.00MM	¥2,208,373.00MM	¥2,470,749.13MM
Operating Cash Flow	¥409,925.00MM	¥447,600.00MM	¥389,790.84MM
Capital expenditure	¥74,258.00MM	¥54,899.00MM	¥76,339.56MM
Investing Cash Flow	¥-37,290.00MM	¥-227,365.00MM	¥-205,051.77MM
Financing Cash Flow	¥-139,331.00MM	¥-141,006.00MM	¥-307,725.29MM
Earnings Per Share**	¥197.80	¥112.47	¥263.96

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.